Transamerica Financial Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54 Buy
+43
New +$81 ﹤0.01% 1867
2025
Q4
Sell
-268
Closed -$764 1863
2025
Q3
$764 Buy
+268
New +$917 ﹤0.01% 1215

Other funds holding HCAT

Transamerica Financial Advisors's HCAT Position: Q1 2026 in Review

Transamerica Financial Advisors opened a new position in Health Catalyst (HCAT) in Q1 2026: 43 shares worth $54. The stake represents ﹤0.01% of the portfolio and ranks #1867 among its holdings. This is a return to the name: Transamerica Financial Advisors previously reported a position in HCAT as recently as Q3 2025.

Transamerica Financial Advisors first reported a position in HCAT in Q3 2025 and has held it in 2 quarters since. The position peaked at $764 in Q3 2025. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Transamerica Financial Advisors held 43 shares of Health Catalyst worth $54 as of Q1 2026.
  • Health Catalyst was a new Transamerica Financial Advisors position in Q1 2026.
  • Health Catalyst made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q1 2026, its #1867 holding.
  • Transamerica Financial Advisors first reported a position in Health Catalyst in Q3 2025 and has held it in 2 quarters since.
  • Transamerica Financial Advisors's Health Catalyst position peaked at $764 in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.